Chronic graft-versus-host disease: clinical manifestation and therapy (Q34339695)

1 August 2017

1 reference

title

Chronic graft-versus-host disease: clinical manifestation and therapy (English)

1 reference

1 August 2017

Ratanatharathorn V

1 reference

1 August 2017

Ayash L

1 reference

1 August 2017

Lazarus HM

1 reference

1 August 2017

Fu J

1 reference

1 August 2017

Uberti JP

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 July 2001

1 reference

Bone Marrow Transplantation

1 August 2017

published in

1 reference

1 August 2017

1 reference

1 August 2017

1 reference

1 August 2017

page(s)

121-129

1 reference

Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703111

Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703111

Histamine release from mouse and rat mast cells cultured with supernatants from chronic murine graft-vs-host splenocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703111

Chronic graft versus host disease: a syndrome of disordered immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703111

Autoantibodies in human chronic graft-versus-host disease after hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703111

Spontaneous factor VIII inhibitor occurring in association with chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703111

Do self-perpetuating B lymphocytes drive human autoimmune disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703111

Differential distribution of Fc gamma RIIIa in normal human tissues and co-localization with DAF and fibrillin-1: implications for immunological microenvironments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703111

Rheumatoid arthritis: the predictable effect of small immune complexes in which antibody is also antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703111

Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703111

Development of a prognostic model for grading chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703111

New perspectives on the etiology of systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703111

21 January 2018

Graft-vs.-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703111

Myasthenia gravis in association with allogeneic bone marrow transplantation: clinical observations, therapeutic implications and review of literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703111

A coded histologic study of hepatic graft-versus-host disease after human bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703111

Neostigmine for the treatment of acute colonic pseudo-obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703111

Vasculitic neuropathy in association with chronic graft-versus-host disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703111

Infection in bone marrow transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703111

Early and late interstitial pneumonia following human bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703111

Bronchiolitis obliterans after bone marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703111

Hydroxychloroquine for the treatment of chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703111

Chronic graft-versus-host disease treated with UVB phototherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703111

Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703111

Anti-CD20 chimeric monoclonal antibody treatment of refractory immune-mediated thrombocytopenia in a patient with chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703111

A three or more drug combination as effective therapy for moderate or severe chronic graft-versus-host disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703111

Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703111

7 January 2021

Acute and chronic graft versus host disease: histopathological evidence for two distinct pathogenetic mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703111

7 January 2021

Graft-versus-host disease and animal models for scleroderma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703111

7 January 2021

Autoimmune diseases and autoimmunity post-bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703111

7 January 2021

Autoimmunity after allogeneic bone marrow transplantation. A study of 53 long-term-surviving patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703111

7 January 2021

Induction of tumor necrosis factor alpha production by adhered human monocytes: a key role for Fcgamma receptor type IIIa in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703111

7 January 2021

The development of chronic graft-versus-host disease: an analysis of screening studies and the impact of corticosteroid use at 100 days after transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703111

7 January 2021

Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703111

7 January 2021

Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703111

7 January 2021

Intestinal and hepatic complications of human bone marrow transplantation. Part II.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703111

7 January 2021

Vaginal stenosis following allogeneic bone marrow transplantation for acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703111

7 January 2021

Fasciitis in chronic graft-versus-host disease. A clinicopathologic study of 14 cases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703111

7 January 2021

Myositis associated with graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703111

7 January 2021

Treatment of oral chronic graft-versus-host disease with PUVA therapy: case report and literature review

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703111

7 January 2021

Oral involvement in chronic graft-versus-host disease after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703111

7 January 2021

Sjögren's syndrome: autoimmune epithelitis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703111

7 January 2021

Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjögren syndrome: a randomized, placebo-controlled, fixed-dose, multicenter trial. P92-01 Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703111

7 January 2021

Cutaneous graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703111

7 January 2021

Phimosis as a manifestation of chronic graft-versus-host disease after allogeneic bone marrow transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703111

7 January 2021

Ocular Manifestations of Graft-vs-Host Disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703111

7 January 2021

Gastrointestinal radiographic features of human graft-vs.-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703111

7 January 2021

Delayed onset of gastrointestinal disease in the recipients of bone marrow transplants. A variant graft-versus-host reaction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703111

7 January 2021

Interstitial pneumonitis following autologous bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703111

7 January 2021

Interstitial pneumonitis after bone marrow transplantation. Assessment of risk factors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703111

7 January 2021

Interstitial pneumonitis after allogeneic bone marrow transplantation. Nine-year experience at a single institution.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703111

7 January 2021

Interstitial pneumonitis associated with human herpesvirus-6 infection after marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703111

7 January 2021

Human herpesvirus 6 in lung tissue from patients with pneumonitis after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703111

7 January 2021

High-resolution computed tomography of bronchiolitis obliterans syndrome after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703111

7 January 2021

Obstructive lung disease after allogeneic marrow transplantation. Clinical presentation and course

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703111

7 January 2021

Polymyositis as a manifestation of chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703111

7 January 2021

Myasthenia gravis and polymyositis as manifestations of chronic graft-versus-host-disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703111

7 January 2021

Myasthenia gravis after allogeneic bone marrow transplantation: relationship to chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703111

7 January 2021

Myasthenia gravis after bone-marrow transplantation. Evidence for a donor origin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703111

7 January 2021

Infection in bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703111

7 January 2021

Risk factors for treatment failures in patients receiving PCR-based preemptive therapy for CMV infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703111

7 January 2021

CD52 antibodies for prevention of graft-versus-host disease and graft rejection following transplantation of allogeneic peripheral blood stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703111

7 January 2021

Changing from cyclosporine to tacrolimus as salvage therapy for chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703111

7 January 2021

The role of thalidomide in the treatment of refractory chronic graft-versus-host disease following bone marrow transplantation in children

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703111

7 January 2021

Thalidomide for the treatment of chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703111

7 January 2021

Extracorporeal photopheresis (ECP) in the treatment of chronic graft-versus-host disease (GVHD)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703111

7 January 2021

Rituximab for myasthenia gravis developing after bone marrow transplant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703111

7 January 2021

Response to thalidomide therapy in refractory chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703111

7 January 2021

Salvage therapy for refractory chronic graft-versus-host disease with mycophenolate mofetil and tacrolimus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703111

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1703111

1 reference

Dimensions Publication ID

1 August 2017

1005925265

0 references

1 reference